Literature DB >> 17339577

Low LDL cholesterol, statins, and brain hemorrhage: should we worry?

Larry B Goldstein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17339577     DOI: 10.1212/01.wnl.0000258538.06950.a1

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  4 in total

Review 1.  Secondary prevention of atherothrombotic events after ischemic stroke.

Authors:  Harold P Adams
Journal:  Mayo Clin Proc       Date:  2009       Impact factor: 7.616

2.  Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.

Authors:  C Baigent; L Blackwell; J Emberson; L E Holland; C Reith; N Bhala; R Peto; E H Barnes; A Keech; J Simes; R Collins
Journal:  Lancet       Date:  2010-11-08       Impact factor: 79.321

3.  Low Cholesterol Levels Increase Symptomatic Intracranial Hemorrhage Rates After Intravenous Thrombolysis: A Multicenter Cohort Validation Study.

Authors:  Sheng-Feng Lin; A-Ching Chao; Han-Hwa Hu; Ruey-Tay Lin; Chih-Hung Chen; Lung Chan; Huey-Juan Lin; Yu Sun; Yung-Yang Lin; Po-Lin Chen; Shinn-Kuang Lin; Cheng-Yu Wei; Yu-Te Lin; Jiunn-Tay Lee; Chyi-Huey Bai
Journal:  J Atheroscler Thromb       Date:  2018-11-21       Impact factor: 4.928

4.  Efficacy and safety of alirocumab, a fully human PCSK9 monoclonal antibody, in high cardiovascular risk patients with poorly controlled hypercholesterolemia on maximally tolerated doses of statins: rationale and design of the ODYSSEY COMBO I and II trials.

Authors:  Helen M Colhoun; Jennifer G Robinson; Michel Farnier; Bertrand Cariou; Dirk Blom; Dean J Kereiakes; Christelle Lorenzato; Robert Pordy; Umesh Chaudhari
Journal:  BMC Cardiovasc Disord       Date:  2014-09-20       Impact factor: 2.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.